We have located links that may give you full text access.
Macular translocation. American Academy of Ophthalmology.
Ophthalmology 2000 May
OBJECTIVE: This document describes macular translocation surgery and examines the evidence to answer four key questions about whether the surgery is effective in treating visual loss from age-related macular degeneration, the technique that is most effective, the complications that result from the procedure, and the relationship of the volume of surgery to the number of complications.
METHODS: A literature search that was conducted in September 1999 retrieved 21 relevant citations, and the reference lists of these articles were consulted for additional citations. Panel members reviewed this information, and a methodologist reviewed and rated all articles as good, fair, or poor in quality.
RESULTS: The published literature contains only information from case series, which lack a control group and randomization. They describe a number of approaches, all of which are evolving. Follow-up is limited and visual outcomes vary widely. Serious intraoperative and postoperative complications are frequent, with accompanying risk of visual loss. Surgical morbidity is also an important factor.
CONCLUSIONS: To date no strong evidence exists with which to answer questions about the effectiveness of macular translocation surgery in treating visual loss from age-related macular degeneration or about the most effective technique. Published case series have reported a significant rate of complications. There is no evidence to date to indicate that the complication rate is related to the volume of surgery done. Randomized clinical trials are needed to determine whether macular translocation is a safe and effective treatment for visual loss from age-related macular degeneration.
METHODS: A literature search that was conducted in September 1999 retrieved 21 relevant citations, and the reference lists of these articles were consulted for additional citations. Panel members reviewed this information, and a methodologist reviewed and rated all articles as good, fair, or poor in quality.
RESULTS: The published literature contains only information from case series, which lack a control group and randomization. They describe a number of approaches, all of which are evolving. Follow-up is limited and visual outcomes vary widely. Serious intraoperative and postoperative complications are frequent, with accompanying risk of visual loss. Surgical morbidity is also an important factor.
CONCLUSIONS: To date no strong evidence exists with which to answer questions about the effectiveness of macular translocation surgery in treating visual loss from age-related macular degeneration or about the most effective technique. Published case series have reported a significant rate of complications. There is no evidence to date to indicate that the complication rate is related to the volume of surgery done. Randomized clinical trials are needed to determine whether macular translocation is a safe and effective treatment for visual loss from age-related macular degeneration.
Full text links
Related Resources
Trending Papers
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app